Meiji Yasuda Life Insurance’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.01M | Hold |
32,069
| – | – | 0.07% | 76 |
|
|
2025
Q4 | $3.06M | Sell |
32,069
-395
| -1% | -$38.7K | 0.09% | 46 |
|
|
2025
Q3 | $3.17M | Buy |
32,464
+64
| +0.2% | +$6.63K | 0.09% | 45 |
|
|
2025
Q2 | $3.48M | Sell |
32,400
-150,301
| -82% | -$15.2M | 0.1% | 41 |
|
|
2025
Q1 | $18.4M | Sell |
182,701
-1,242
| -0.7% | -$125K | 0.37% | 26 |
|
|
2024
Q4 | $16.4M | Sell |
183,943
-14,429
| -7% | -$1.27M | 0.31% | 26 |
|
|
2024
Q3 | $16.6M | Buy |
198,372
+2,599
| +1% | +$205K | 0.31% | 28 |
|
|
2024
Q2 | $15.1M | Buy |
195,773
+127,205
| +186% | +$9.31M | 0.3% | 30 |
|
|
2024
Q1 | $4.7M | Buy |
68,568
+22,725
| +50% | +$1.46M | 0.1% | 63 |
|
|
2023
Q4 | $2.65M | Buy |
45,843
+22,833
| +99% | +$1.22M | 0.06% | 85 |
|
|
2023
Q3 | $1.21M | Buy |
23,010
+19,245
| +511% | +$1.01M | 0.03% | 143 |
|
|
2023
Q2 | $204K | Buy |
+3,765
| New | +$197K | 0.01% | 260 |
|
|
2023
Q1 | – | Sell |
-9,852
| Closed | -$456K | – | 269 |
|
|
2022
Q4 | $456K | Sell |
9,852
-1,317
| -12% | -$57K | 0.01% | 226 |
|
|
2022
Q3 | $433K | Sell |
11,169
-14
| -0.1% | -$562 | 0.01% | 225 |
|
|
2022
Q2 | $417K | Buy |
11,183
+5,966
| +114% | +$243K | 0.01% | 209 |
|
|
2022
Q1 | $231K | Sell |
5,217
-1,169
| -18% | -$50.7K | ﹤0.01% | 283 |
|
|
2021
Q4 | $271K | Sell |
6,386
-5,640
| -47% | -$237K | ﹤0.01% | 286 |
|
|
2021
Q3 | $522K | Buy |
12,026
+4,060
| +51% | +$180K | 0.01% | 223 |
|
|
2021
Q2 | $341K | Sell |
7,966
-1,813
| -19% | -$76.3K | 0.01% | 274 |
|
|
2021
Q1 | $378K | Buy |
9,779
+1,800
| +23% | +$68.1K | 0.01% | 254 |
|
|
2020
Q4 | $287K | Buy |
7,979
+1,253
| +19% | +$45.2K | 0.01% | 275 |
|
|
2020
Q3 | $257K | Buy |
6,726
+200
| +3% | +$7.71K | 0.01% | 289 |
|
|
2020
Q2 | $229K | Buy |
+6,526
| New | +$235K | 0.01% | 277 |
|
|
2020
Q1 | – | Sell |
-8,208
| Closed | -$371K | – | 272 |
|
|
2019
Q4 | $371K | Buy |
+8,208
| New | +$343K | 0.05% | 263 |
|
|
2019
Q1 | – | Sell |
-9,400
| Closed | -$332K | – | 306 |
|
|
2018
Q4 | $332K | Buy |
+9,400
| New | +$341K | 0.05% | 279 |
|
|
2017
Q3 | – | Sell |
-9,800
| Closed | -$272K | – | 308 |
|
|
2017
Q2 | $272K | Hold |
9,800
| – | – | 0.04% | 290 |
|
|
2017
Q1 | $244K | Buy |
+9,800
| New | +$238K | 0.04% | 293 |
|
|
2015
Q1 | – | Sell |
-14,965
| Closed | -$198K | – | 317 |
|
|
2014
Q4 | $198K | Hold |
14,965
| – | – | 0.03% | 382 |
|
|
2014
Q3 | $177K | Buy |
14,965
+517
| +4% | +$6.51K | 0.03% | 376 |
|
|
2014
Q2 | $185K | Hold |
14,448
| – | – | 0.03% | 367 |
|
|
2014
Q1 | $195K | Hold |
14,448
| – | – | 0.03% | 355 |
|
|
2013
Q4 | $174K | Hold |
14,448
| – | – | 0.03% | 359 |
|
|
2013
Q3 | $170K | Sell |
14,448
-1,043
| -7% | -$11.3K | 0.03% | 349 |
|
|
2013
Q2 | $144K | Buy |
+15,491
| New | +$131K | 0.03% | 347 |
|
Other funds holding BSX
VCM
VPM
Meiji Yasuda Life Insurance's BSX Position: Q1 2026 in Review
Meiji Yasuda Life Insurance held its Boston Scientific (BSX) position steady in Q1 2026 at 32,069 shares worth $2.01M. The position accounts for 0.07% of the portfolio, ranked #76.
Meiji Yasuda Life Insurance first reported a position in BSX in Q2 2013 and has held it in 34 quarters since. The position peaked at $18.4M in Q1 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Meiji Yasuda Life Insurance held 32,069 shares of Boston Scientific worth $2.01M as of Q1 2026.
- Meiji Yasuda Life Insurance left its Boston Scientific share count unchanged in Q1 2026.
- Boston Scientific made up 0.07% of Meiji Yasuda Life Insurance's portfolio in Q1 2026, its #76 holding.
- Meiji Yasuda Life Insurance first reported a position in Boston Scientific in Q2 2013 and has held it in 34 quarters since.
- Meiji Yasuda Life Insurance's Boston Scientific position peaked at $18.4M in Q1 2025.
- 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Meiji Yasuda Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.